Attivare Therapeutics, Inc.
Personalized cancer immunotherapy combining intratumoral immune agonist delivery via biomaterial scaffolds and AI-driven patient-specific drug selection using single-cell transcriptomics
- Sector
- Biotech
- Headquarters
- NATICK, MA
- Founded
- 2020
- Latest Form D
- $4.8M, Sep 2021
- Total capital
- $4.8M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $4.8M
- 1 Form D · last Sep 2021
- 62 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 7 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$4.8M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Edward DohertyExecutive Officer, DirectorNamed in SEC Form D filings
- Jessica McDonoughDirectorNamed in SEC Form D filings
- Joaquim TriasExecutive Officer, DirectorNamed in SEC Form D filings
- Zeshan MuhammediDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 7- PendingIntertumoral And Intratumoral Delivery Of Cytokines Using Mesoporous Silica Rods As An Immunomodulating SystemUSPTOApplication 19146486
- PendingMethod Of Use Of Mesoporous Silica Rods For Treating CancerUSPTOApplication PCTUS2024052802
- PendingIntertumoral And Intratumoral Delivery Of Cytokines Using Mesoporous Silica Rods As An Immunomodulating SystemUSPTOApplication PCTUS2024010752
Show all 7 patent records
- Intertumoral And Intratumoral Delivery Of Cytokines Using Mesoporous Silica Rods As An Immunomodulating SystemJul 30, 2026 · Application 19146486Pending
- Method Of Use Of Mesoporous Silica Rods For Treating CancerApplication PCTUS2024052802Pending
- Intertumoral And Intratumoral Delivery Of Cytokines Using Mesoporous Silica Rods As An Immunomodulating SystemApplication PCTUS2024010752Pending
- Intertumoral And Intratumoral Delivery Of Cytokines Using Mesoporous Silica Rods As An Immunomodulating SystemApplication 63599507Pending
- Method Of Use Of Mesoporous Silica Rods For Treating CancerApplication 63545547Pending
- Intertumoral And Intratumoral Delivery Of Cytokines Using Mesoporous Silica Rods As An Immunomodulating SystemApplication 63437747Pending
- Method Of Use Of Mesoporous Silica Rods For Treating CancerApplication 19581955Pending
Related companies, and why
- Manifold Technologies Ltd.Similar federal contract value in Biotech · null in contracts
- Virax Biolabs Group LtdSimilar federal contract value in Biotech · null in contracts
- MingSight Pharmaceuticals, Inc.Similar federal contract value in Biotech · null in contracts
- Inventprise LLCSimilar federal contract value in Biotech · null in contracts
- YAP Therapeutics IncSimilar federal contract value in Biotech · null in contracts
- La Jolla Labs IncSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .